Invention Application
- Patent Title: ANTI-C-MET ANTIBODY DRUG CONJUGATES
-
Application No.: US17661450Application Date: 2022-04-29
-
Publication No.: US20220378935A1Publication Date: 2022-12-01
- Inventor: Andrew C. PHILLIPS , Regina M. REILLY , George A. DOHERTY , Cheng JI , Milan BRUNCKO , Erwin R. BOGHAERT , Mark ANDERSON
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: A61K47/68
- IPC: A61K47/68 ; C07K16/28 ; A61P35/00 ; C07K5/068 ; C07D491/22
Abstract:
The present disclosure provides c-Met antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
Public/Granted literature
- US11633497B2 Anti-c-Met antibody drug conjugates Public/Granted day:2023-04-25
Information query
IPC分类:
